sCAVA - Sleep Assessment Using the CAVA Device
NCT: NCT04583826 · COMPLETED
Brief Summary
Clinical investigation of a medical device (CAVA) for recording eye movements. Forty volunteers will sleep in a specially designed sleep lab for one or two nights, depending on whether they are enrolled onto phase 1 (two nights) or phase 2 (one night) of the study. Each volunteer will wear the CAVA device along with a Polysomnography (PSG) device, which is the gold standard for monitoring sleep. The twenty participants in phase 2 will simultaneously wear a commercially available consumer device for monitoring sleep. The eye movement data captured using CAVA will be processed by novel computer algorithms to classify the sleep stages in the data into Rapid Eye Movement (REM), non-REM and awake. The results will be compared with the ground-truth from the gold standard, and also compared to the results from the commercially available device. The aim of the study is to determine whether CAVA could be a viable and competitive home-monitoring device for analysing sleep.
Frequently Asked Questions
What is sCAVA - Sleep Assessment Using the CAVA Device?
sCAVA - Sleep Assessment Using the CAVA Device is a clinical trial registered under NCT04583826. Current status: COMPLETED.
What is the status of NCT04583826?
The current status of NCT04583826 (sCAVA - Sleep Assessment Using the CAVA Device) is: COMPLETED.
When did sCAVA - Sleep Assessment Using the CAVA Device start?
sCAVA - Sleep Assessment Using the CAVA Device started on 2020-04-02.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.